Back to search

Article

A scalable screening platform for phenotypic subtyping of ALS patient-derived fibroblasts

2022-09-28

Abstract excerpt

<h4>ABSTRACT</h4> A major challenge for understanding and treating Amyotrophic Lateral Sclerosis (ALS) is that most patients have no known genetic cause. Even within defined genetic subtypes, patients display considerable clinical heterogeneity. It is unclear how to identify subsets of ALS patients that share common molecular dysregulation or could respond similarly to treatment. Here, we developed a scalable mic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fc786e71-02a1-5b9e-848d-0f41d89e2930
DOI
10.1101/2022.09.27.509770
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A scalable screening platform for phenotypic subtyping of ALS patient-derived fibroblastsDOI 10.1101/2022.09.27.509770
Select a neighboring publication to make it the new centre.